Is digital pathology the new standard in MASH trials?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is digital pathology the new standard in MASH trials?

Published:2024-06-17 Issue: Volume: Page:
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:

Author:

Wang Yue¹²,Wong Vincent Wai-Sun¹²^ORCID

Affiliation:

1. Department of Medicine and Therapeutics, Medical Data Analytics Center, The Chinese University of Hong Kong, Hong Kong, China

2. State Key Laboratory of Digestive Disease, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference10 articles.

1. Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis;Taylor;Gastroenterology,2020

2. Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials;Davison;J Hepatol,2020

3. Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis;Sanyal;J Hepatol,2023

4. Aramchol improves hepatic fibrosis in NASH: Results of multimodality assessment using both conventional and digital pathology;Ratziu;Hepatology,2024

5. Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis;Ratziu;Hepatology,2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP